Drug
Injection of 18F-FDG
Injection of 18F-FDG is a pharmaceutical drug with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph not_applicable
1
33%
Ph early_phase_1
1
33%
Ph phase_2
1
33%
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Recruiting2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Early Phase 11 (33.3%)
Phase 21 (33.3%)
N/A1 (33.3%)
Trials by Status
recruiting267%
unknown133%
Recent Activity
2 active trials
Showing 3 of 3
recruitingearly_phase_1
Clinical Application of 68Ga-FL-031 PET in the Diagnosis and Staging of Malignant Tumors
NCT07301801
recruitingnot_applicable
Intermittent Cold Exposure and Brown Adipose Tissue Hyperplasia
NCT07048405
unknownphase_2
uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer
NCT02805608
Clinical Trials (3)
Showing 3 of 3 trials
NCT07301801Early Phase 1
Clinical Application of 68Ga-FL-031 PET in the Diagnosis and Staging of Malignant Tumors
NCT07048405Not Applicable
Intermittent Cold Exposure and Brown Adipose Tissue Hyperplasia
NCT02805608Phase 2
uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3